LIS
NVO

Legacy Investment Solutions’s Novo Nordisk NVO Stock Holding History

Legacy Investment Solutions’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.52K Buy
+109
New +$7.41K ﹤0.01% 351
2024
Q4 		$9.42K Hold
109
– – 0.01% 297
2024
Q3 		$11.7K Buy
+109
New +$14.5K 0.01% 288

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Legacy Investment Solutions's NVO Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Novo Nordisk (NVO) in Q2 2025: 109 shares worth $7.52K. The stake represents ﹤0.01% of the portfolio and ranks #351 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in NVO as recently as Q4 2024.

Legacy Investment Solutions first reported a position in NVO in Q3 2024 and has held it in 3 quarters since. The position peaked at $11.7K in Q3 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Legacy Investment Solutions held 109 shares of Novo Nordisk worth $7.52K as of Q2 2025.
  • Novo Nordisk was a new Legacy Investment Solutions position in Q2 2025.
  • Novo Nordisk made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #351 holding.
  • Legacy Investment Solutions first reported a position in Novo Nordisk in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Novo Nordisk position peaked at $11.7K in Q3 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.